Utah Medical Products (UTMD) Accumulated Expenses (2010 - 2026)

Utah Medical Products' Accumulated Expenses history runs 17 years deep, the most recent figure standing at $2.3 million for Q1 2026.

• On a quarterly basis, Accumulated Expenses fell 32.23% year-over-year to $2.3 million in Q1 2026; TTM through Mar 2026 was $2.3 million, a 32.23% decrease from a year earlier, with the FY2025 full-year figure at $1.7 million, up 1419.82% from the prior year.
• Accumulated Expenses grew to $2.3 million in Q1 2026 per UTMD's latest filing, from $1.7 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $5.0 million in Q1 2023 and bottomed at $111000.0 in Q4 2024.
• The 5-year median for Accumulated Expenses is $3.1 million (2024), against an average of $2.9 million.
• Across the five-year window, Accumulated Expenses plunged 91.42% in 2024 and jumped 1419.82% in 2025, its largest moves.
• Year by year, Accumulated Expenses stood at $1.3 million in 2022, then slipped by 1.82% to $1.3 million in 2023, then plunged by 91.42% to $111000.0 in 2024, then soared by 1419.82% to $1.7 million in 2025, then surged by 36.99% to $2.3 million in 2026.
• Per Business Quant, the three latest UTMD Accumulated Expenses figures stand at $2.3 million (Q1 2026), $1.7 million (Q4 2025), and $2.2 million (Q3 2025).